Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Ketorolac Tromethamine Injection
Status: Currently in Shortage
»Date first posted:
03/23/2018
»Therapeutic Categories: Analgesia/Addiction
Alembic Pharmaceuticals (Reverified 05/15/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25) | Available | ||
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25) | Available | ||
| Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25) | Available |
Baxter Healthcare (Revised 09/04/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25) | Unavailable | Estimated recovery: November 2026 | Demand increase for the drug |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10) | Unavailable | Estimated recovery: November 2026 | Demand increase for the drug |
Fresenius Kabi USA, LLC (Reverified 09/15/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10) | Unavailable | Estimated recovery: TBD | Other |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10) | Unavailable | Estimated recovery: TBD | Other |
| Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20) | Unavailable | Estimated recovery: TBD | Other |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01) | Available | Check wholesalers for inventory | |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01) | Unavailable | Next release September 2026. Check wholesalers for inventory. | Delay in shipping of the drug |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02) | Unavailable | Next release September 2026. Check wholesalers for inventory. | Delay in shipping of the drug |
Gland Pharma Limited (Reverified 07/22/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) | Available | Demand increase for the drug | |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) | Available | ||
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) | Available | Demand increase for the drug | |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25) | Available | Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. | Demand increase for the drug |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25) | Available | Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. | Demand increase for the drug |
Hikma Pharmaceuticals USA, Inc. (Revised 09/03/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25) | Unavailable | Estimated recovery: TBD | Other |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25) | Unavailable | Estimated recovery: TBD | Other |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25) | Unavailable | Estimated recovery: TBD | Other |
Hospira, Inc., a Pfizer Company (Revised 09/09/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01) | Unavailable | Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01) | Unavailable | Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01) | Unavailable | Next Estimated Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
Sagent Pharmaceuticals (Revised 08/18/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) | Limited Availability | Estimated recovery: late September 2026 | Delay in shipping of the drug |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) | Available | ||
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) | Available |